(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.02%) $0.927
(-0.15%) $10.82
(-0.14%) $0.791
(-0.24%) $92.35
3 days till quarter result
(bmo 2024-04-01)
Expected move: +/- 13.81%
Live Chart Being Loaded With Signals
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States...
Stats | |
---|---|
Today's Volume | 15 331.00 |
Average Volume | 54 206.00 |
Market Cap | 994 782 |
EPS | $0 ( 2024-03-25 ) |
Next earnings date | ( $0 ) 2024-04-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0800 |
ATR14 | $0.0110 (1.37%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-13 | Dey Svetlana | Buy | 500 | Common Stock |
2023-12-13 | Dey Indranil | Buy | 500 | Common Stock |
2023-09-26 | Scally Frances P | Buy | 0 | |
2023-03-24 | Dey Svetlana | Buy | 10 000 | Common Stock |
2023-03-28 | Dey Indranil | Buy | 2 000 | Common Stock |
INSIDER POWER |
---|
44.55 |
Last 55 transactions |
Buy: 889 772 | Sell: 456 992 |
Bluejay Diagnostics, Inc. Correlation
10 Most Positive Correlations | |
---|---|
BPYPP | 0.971 |
ISTR | 0.97 |
ADES | 0.968 |
SFBS | 0.968 |
FFWM | 0.966 |
SGMO | 0.965 |
NUWE | 0.965 |
FSEA | 0.964 |
ARVL | 0.964 |
IMBI | 0.962 |
10 Most Negative Correlations | |
---|---|
MSDA | -0.972 |
BRIVU | -0.97 |
VLAT | -0.964 |
ADAL | -0.962 |
TIOAU | -0.961 |
TIOA | -0.96 |
PPYAU | -0.956 |
ZING | -0.956 |
NVCN | -0.953 |
BRIV | -0.952 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Bluejay Diagnostics, Inc. Financials
Annual | 2022 |
Revenue: | $249 040 |
Gross Profit: | $48 911.00 (19.64 %) |
EPS: | $-9.15 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-270 785 (0.00 %) |
EPS: | $-2.08 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $-293 502 (0.00 %) |
EPS: | $-2.75 |
Q1 | 2023 |
Revenue: | $0 |
Gross Profit: | $-160 345 (0.00 %) |
EPS: | $-2.20 |
Financial Reports:
No articles found.
Bluejay Diagnostics, Inc.
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators